Charles E. Collins IV - 16 Apr 2026 Form 4 Insider Report for ARGAN INC (AGX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
20 Apr 2026, 17:00:13 UTC
Prior SEC filing
10 Apr 2026
Next SEC filing
22 Apr 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Charles E. Collins IV

Key filing fact

Charles E. Collins IV filed Form 4 for ARGAN INC (AGX) on 20 Apr 2026.

Key facts

  • This page summarizes Charles E. Collins IV's Form 4 filing for ARGAN INC (AGX).
  • 16 reported transactions and 8 derivative rows are listed below.
  • Accepted by SEC: 20 Apr 2026, 17:00.

Change

  • Previous filing in this sequence was filed on 10 Apr 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001791800 Primary reporting owner

Collins Charles Edwin IV

Relationship
CHIEF EXECUTIVE OFFICER, GEMMA
Address
C/O ARGAN, INC., 4075 WILSON BLVD, SUITE 440, ARLINGTON
Signature
/s/ Charles E. Collins IV
Signature date
20 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AGX transaction

Common Stock

Options Exercise

Transaction value
Shares
+548
Change %
+2.6%
Price
$0.000000*
Shares after
21,554
Date
16 Apr 2026
Ownership
Direct
Footnotes
F1
AGX transaction

Common Stock

Options Exercise

Transaction value
Shares
+270
Change %
+1.3%
Price
$0.000000*
Shares after
21,824
Date
16 Apr 2026
Ownership
Direct
Footnotes
F2
AGX transaction

Common Stock

Options Exercise

Transaction value
Shares
+730
Change %
+3.3%
Price
$0.000000*
Shares after
22,554
Date
16 Apr 2026
Ownership
Direct
Footnotes
F3
AGX transaction

Common Stock

Options Exercise

Transaction value
Shares
+360
Change %
+1.6%
Price
$0.000000*
Shares after
22,914
Date
16 Apr 2026
Ownership
Direct
Footnotes
F4
AGX transaction

Common Stock

Options Exercise

Transaction value
Shares
+2,813
Change %
+12%
Price
$0.000000*
Shares after
25,727
Date
17 Apr 2026
Ownership
Direct
Footnotes
F5
AGX transaction

Common Stock

Options Exercise

Transaction value
Shares
+1,125
Change %
+4.4%
Price
$0.000000*
Shares after
26,852
Date
17 Apr 2026
Ownership
Direct
Footnotes
F6
AGX transaction

Common Stock

Options Exercise

Transaction value
Shares
+2,531
Change %
+9.4%
Price
$0.000000*
Shares after
29,383
Date
17 Apr 2026
Ownership
Direct
Footnotes
F7
AGX transaction

Common Stock

Options Exercise

Transaction value
Shares
+937
Change %
+3.2%
Price
$0.000000*
Shares after
30,320
Date
17 Apr 2026
Ownership
Direct
Footnotes
F8

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AGX transaction Derivative

Renewable Performance Based Restricted Stock Units

Options Exercise

Transaction value
Shares
-1,000
Change %
-9.1%
Price
$0.000000*
Shares after
10,000
Date
16 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,000
Exercise price
$0.000000
Footnotes
F1
AGX transaction Derivative

Renewable Performance Based Restricted Stock Units

Options Exercise

Transaction value
Shares
-500
Change %
-5%
Price
$0.000000*
Shares after
9,500
Date
16 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
500
Exercise price
$0.000000
Footnotes
F2
AGX transaction Derivative

Time Based Restricted Stock Units

Options Exercise

Transaction value
Shares
-1,333
Change %
-20%
Price
$0.000000*
Shares after
5,231
Date
16 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,333
Exercise price
$0.000000
Footnotes
F3
AGX transaction Derivative

Time Based Restricted Stock Units

Options Exercise

Transaction value
Shares
-667
Change %
-13%
Price
$0.000000*
Shares after
4,564
Date
16 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
667
Exercise price
$0.000000
Footnotes
F4
AGX transaction Derivative

Earnings Per Share Performance Based Restricted Stock Units

Options Exercise

Transaction value
Shares
-2,500
Change %
-25%
Price
$0.000000*
Shares after
7,618
Date
17 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,500
Exercise price
$0.000000
Footnotes
F5
AGX transaction Derivative

Performance Based Restricted Stock Units

Options Exercise

Transaction value
Shares
-1,000
Change %
-37%
Price
$0.000000*
Shares after
1,670
Date
17 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,000
Exercise price
$0.000000
Footnotes
F6
AGX transaction Derivative

Renewable Performance Based Restricted Stock Units

Options Exercise

Transaction value
Shares
-4,500
Change %
-47%
Price
$0.000000*
Shares after
5,000
Date
17 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,500
Exercise price
$0.000000
Footnotes
F7
AGX transaction Derivative

Time Based Restricted Stock Units

Options Exercise

Transaction value
Shares
-1,666
Change %
-37%
Price
$0.000000*
Shares after
2,898
Date
17 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,666
Exercise price
$0.000000
Footnotes
F8
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 8 footnotes

Footnote F1

Pursuant to the one-year performance period vesting schedule of the Renewable Performance-Based Restricted Stock Units ("RRSUs") awarded to the Reporting Person on April 16, 2024, 1,000 shares of the Issuer's common stock became issuable to the Reporting Person on April 16, 2026 and is adjusted for dividends.

Footnote F2

Pursuant to the one-year performance period vesting schedule of the RRSUs awarded to the Reporting Person on April 16, 2025, 500 shares of the Issuer's common stock became issuable to the Reporting Person on April 16, 2026 and is adjusted for dividends.

Footnote F3

Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Units ("TRSUs") awarded to the Reporting Person on April 16, 2024, 1,333 shares of the Issuer's common stock became issuable to the Reporting Person on April 16, 2026 and is adjusted for dividends.

Footnote F4

Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on April 16, 2025, 667 shares of the Issuer's common stock became issuable to the Reporting Person on April 16, 2026 is adjusted for dividends.

Footnote F5

Pursuant to three-year performance period vesting schedule of the Earnings Per Share Performance-Based Restricted Stock Units ("ERSUs") awarded to the Reporting Person on April 17, 2023, 5,000 shares of the Issuer's common stock became issuable to the Reporting Person on April 17, 2026 and is adjusted for dividends. The target number of shares was 2,500.

Footnote F6

Pursuant to three-year performance period vesting schedule of the Performance Based Restricted Stock Units ("PRSUs") awarded to the Reporting Person on April 17, 2023, 2,000 shares of the Issuer's common stock became issuable to the Reporting Person on April 17, 2026 and is adjusted for dividends. The target number of shares was 1,000.

Footnote F7

Pursuant to the one-year performance period vesting schedule of the RRSUs awarded to the Reporting Person on April 17, 2023, 4,500 shares of the Issuer's common stock became issuable to the Reporting Person on April 17, 2026 and is adjusted for dividends.

Footnote F8

Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on April 17, 2023, 1,666 shares of the Issuer's common stock became issuable to the Reporting Person on April 17, 2026 and is adjusted for dividends.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .